JWA
RCUS icon

JFS Wealth Advisors’s Arcus Biosciences RCUS Stock Holding History

JFS Wealth Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247 Buy
+8
New +$198 ﹤0.01% 2109
2024
Q4 		– Sell
-7
Closed -$108 – 1985
2024
Q3 		$108 Sell
7
-1
-13% -$16 ﹤0.01% 1900
2024
Q2 		$122 Hold
8
– – ﹤0.01% 1920
2024
Q1 		$152 Buy
8
+1
+14% +$17 ﹤0.01% 1914
2023
Q4 		$134 Sell
7
-4
-36% -$64 ﹤0.01% 1938
2023
Q3 		$198 Buy
11
+2
+22% +$40 ﹤0.01% 1862
2023
Q2 		$183 Buy
9
+7
+350% +$133 ﹤0.01% 1885
2023
Q1 		$37 Sell
2
-14
-88% -$268 ﹤0.01% 1933
2022
Q4 		$331 Buy
16
+6
+60% +$165 ﹤0.01% 1793
2022
Q3 		$0 Buy
10
+8
+400% +$212 ﹤0.01% 1892
2022
Q2 		$0 Sell
2
-2
-50% -$49 ﹤0.01% 1902
2022
Q1 		$0 Buy
4
+2
+100% +$67 ﹤0.01% 1939
2021
Q4 		$0 Buy
+2
New +$78 ﹤0.01% 1849

Other funds holding RCUS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

JFS Wealth Advisors's RCUS Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 8 shares worth $247. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in RCUS as recently as Q3 2024.

JFS Wealth Advisors first reported a position in RCUS in Q4 2021 and has held it in 13 quarters since. The position peaked at $331 in Q4 2022. 17 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • JFS Wealth Advisors held 8 shares of Arcus Biosciences worth $247 as of Q2 2026.
  • Arcus Biosciences was a new JFS Wealth Advisors position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2109 holding.
  • JFS Wealth Advisors first reported a position in Arcus Biosciences in Q4 2021 and has held it in 13 quarters since.
  • JFS Wealth Advisors's Arcus Biosciences position peaked at $331 in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.